BOOSTING ONCOLOGY RESEARCH WITH INTEGRATED KRAS ASSAY PROVIDERS AND RAS ASSAYS

during the speedily evolving field of oncology exploration, accurate and efficient mutation screening is important for developing targeted therapies. The KRAS companies Platform plays a pivotal role With this landscape by offering comprehensive methods for KRAS mutation profiling and Investigation. KRAS mutations, found in roughly ninety five% of R